Dr. Adriany was involved in pioneering efforts with the world’s first 7T and 9.4T magnets and most recently with the U of MN 10.5T. He is an expert in MR antenna development and design of specialized imaging hardware for high and ultra high magnetic fields.
My research interests are in developing structural and functional magnetic resonance imaging (MRI) techniques at high fields for improving the diagnostic quality in clinical and research applications.
Dr. Harel leads the team at the Center for Magnetic Resonance Research (CMRR) that are developing tools to visualize the anatomical structures of the the basal ganglia using a powerful (7 Tesla) MRI machine. These unique new imaging methods provide a precise map of the brain's targets areas, the different nuclei and their anatomical connections, that are critically important for the success of DBS treatment.
I serve as the neuropsychologist for the movement disorders surgery team and am participating in research involving the cognitive effects of deep brain stimulation. In addition, I am currently developing a dataset neuropsychological evaluations of all patients who have undergone deep brain stimulation surgery at this institution since approximately 2006, in collaboration with the Neurology department.
I am a clinical neurologist specializing in movement disorders and a research physiologist specializing in control of voluntary movement. My goal is to combine the two roles fruitfully. My lab studies the extrapyramidal motor system in humans with an emphasis on disease states and neurosurgical therapies. The lab's focus is on the basal ganglia (BG) and on Parkinson's disease (PD).
Since arriving at the University of Minnesota in 1996, Dr. Tuite has directed more than 30 clinical trials related to Parkinson's disease (PD) and other movement disorders. In addition to evaluating new therapies, his interests include the development of novel brain MRI and nuclear imaging tests that may aid in the diagnosis of PD, increase out understanding of the disease, and monitor the effects of treatment. Dr.
I am a statistician and have collaborated in neurology and neuroscience for more than 15 years. I work directly on the design of the research and with the data collected during the research. It is important to me to understand the implications of the research on patient prognosis and well-being. This understanding also enhances my ability to make meaningful contributions to the research. I have been the Director of two other Biostatistics Cores, one supporting the research of the U.S.
John E. Connett, PhD is Professor of Biostatistics and Director of the CTSI's Biostatistical Design and Analysis Center. Dr. Connett's expertise is in the design, conduct, and analysis of clinical trials. Dr.
